Atopic Dermatitis Disease Biomarkers Strongly Correlate With IL-13 Levels, Are Regulated by IL-13, and Are Modulated by Tralokinumab in Vitro. J of Skin 2019, 3, S42. https://doi.org/10.25251/skin.3.supp.42.